Navigation Links
Lung Disease Tied to Increased Risk for Cardiac Events
Date:12/5/2008

IPF patients 3 times more likely to suffer heart problems, study says

FRIDAY, Dec. 5 (HealthDay News) -- People with the deadly lung disease idiopathic pulmonary fibrosis (IPF) are three times more likely than people without the disease to suffer severe cardiac events such as a heart attack, according to a British study.

"If you look at them over time, people with IPF have roughly a threefold increased risk of acute coronary syndrome, which is a greater increase than you get from smoking," lead author Dr. Richard B. Hubbard, a professor of epidemiology at the University of Nottingham, said in an American Thoracic Society news release.

Hubbard and his colleagues analyzed data from 920 IPF patients and 3,593 people without the disease. In addition to being at increased risk for heart attacks, IPF patients were 23 percent more likely to have angina, 60 percent more likely to have a stroke, and three times more likely to develop deep vein thrombosis.

The researchers also found that IPF patients were more than twice as likely to have been prescribed amiodarone, a medication used to treat irregular heartbeats. The drug has been implicated as a cause of fibrotic lung disease, the researchers said.

The study was published in the second issue for December of the American Journal of Respiratory and Critical Care Medicine.

About 60,000 people in the United States have IPF, and 21,000 new cases are diagnosed each year. Median survival from the time of diagnosis is about three years. Currently, there are no treatments known to increase survival. Medical knowledge about IPF is limited.

"We know that genetic factors play some role in IPF, because it clusters in families in about 10 percent of cases, and in a similar number of people, there is evidence that environmental factors, such as exposure to metal dust at work and cigarette smoking may have a role," Hubbard said. "But studies from the U.S.A. and U.K. suggest that IPF is becoming more common, and the reasons for this are unclear."

In an accompanying editorial, Dr. David Zisman and Dr. Steven Kawut said further research is needed "to better understand the relationship between IPF and systemic vascular disease as well as the mechanisms shared by the two syndromes."

If studies confirm a causal relationship, "the presence of IPF itself could constitute a sufficiently potent risk factor for coronary artery disease such that more aggressive goals in risk factor modification would be warranted."

More information

The U.S. National Heart, Lung, and Blood Institute has more about IPF.



-- Robert Preidt



SOURCE: American Thoracic Society, news release, Dec. 5, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Double threat: Deadly lung disease also linked to heart attacks
2. 50th Annual Meeting of the American Society of Hematology Will Feature Breakthrough Research in Blood Diseases
3. Researchers identify cell group key to Lyme disease arthritis
4. Study shows school-based program enables children and adolescents to better manage chronic disease
5. CA$2.4 million toward gene therapy for human degenerative retinal diseases
6. Diagnosis and Drug Treatment of Alzheimers Disease in China is Low and Will Remain Low Through 2012
7. Vaccine and drug research aimed at ticks and mosquitoes to prevent disease transmission
8. Dental and Medical Communities Piloting Partnership in Mid-Michigan To Detect and Defeat Disease
9. Large study illustrates cardiac CT can effectively assess coronary artery disease
10. Novel Techniques Offers New Freedom to Patients with Parkinson's Disease, Epilepsy, Dystonia, and Tremor
11. Nine Year Ban Fails to Eradicate Asbestos Related Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Lung Disease Tied to Increased Risk for Cardiac Events
(Date:2/26/2017)... ... , ... IndustryArchive.Org . is announcing a new way for B2B Sellers ... only pay for B.A.N.T. quality sales leads based on the Sellers decision to purchase ... reality that B2B buyers are controlling the sales process via the Internet and that ...
(Date:2/26/2017)... ... ... ODH, Inc.™ announced today it will exhibit and speak at the 10th ... Arlington, VA. ODH’s director of medical strategy, Candace Saldarini, M.D., will present on how ... management. , ODH will also have an exhibit booth where attendees may speak to ...
(Date:2/26/2017)... ... February 26, 2017 , ... Occupational pesticide ... with a specific LRRK2 mutation, according to a study released today at the ... evidence of a link between pesticides and incidence of sporadic PD through occupational ...
(Date:2/24/2017)... ... February 24, 2017 , ... HealthPostures, ... Go. Core benefits and advantages built into the home office sit stand solution ... and feel. Ability to gain the benefits embedded in the TaskMate Go are ...
(Date:2/24/2017)... ... February 24, 2017 , ... Only two months after the official release ... show in Cannes (France), XO Private has initiated a second print-run of its lavish ... almost a metre across when open, weighs in at more than six kilos, retails ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... DUBLIN , Feb. 24, 2017 Research ... Health Market Analysis & Trends - Industry Forecast to 2025" ... ... at a CAGR of around 23.8% over the next decade to ... analyzes the market estimates and forecasts for all the given segments ...
(Date:2/24/2017)... Research and Markets has announced the addition of ... to 2025" report to their offering. ... The Global Empty Capsules Market is poised to grow ... approximately $2.9 billion by 2025. This industry report analyzes ... as well as regional levels presented in the research scope. The study ...
(Date:2/24/2017)... Research and Markets has announced the addition of the "Dry ... offering. ... Dry eye Drugs Price Analysis and Strategies - 2016, provides drug pricing ... answers the following questions: What are the ... they positioned in the Global Dry eye market? What ...
Breaking Medicine Technology: